Neuropace, Inc. Common Stock (NASDAQ: NPCE) last traded at $14.03, up 0.07% on the session. The quote above updates while this page is open; the figures below are drawn from Neuropace, Inc. Common Stock’s own filings and are restated only when a new one is published.
Neuropace, Inc. Common Stock trades on NASDAQ under the ticker NPCE. Its market capitalisation is $481.57 million.
Valuation measures for Neuropace, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $481.57M |
|---|---|
| Enterprise value | $554.14M |
| Price / sales | 4.87 |
| Price / book | 40.53 |
| Beta | 1.47 |
Trailing-twelve-month figures tagged in Neuropace, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $98.84M |
|---|---|
| Net income (TTM) | -$19.11M |
| EPS (TTM) | -$0.570 |
| Gross margin | 81.57% |
| Operating margin | -13.87% |
| Return on equity | -160.85% |
| Cash | $12.54M |
Range and volume for NPCE over the past 52 weeks.
| 52-week high | $19.60 |
|---|---|
| 52-week low | $8.61 |
| Volume | 115.2K |
| Average volume | 189.3K |
| Previous close | $14.02 |
Dividend history for Neuropace, Inc. Common Stock over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.